Remepy
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
$36MSeries A
Role not disclosedLoading investors…
Loading investors…
Activity from announced rounds
Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps
Builds AI-powered go-to-market engineering systems for revenue teams
Provides software-driven spectrum intelligence for defense aerospace and mobility systems